Corvus Pharmaceuticals
(NASDAQ:CRVS)
Corvus Pharmaceuticals, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Corvus Pharmaceuticals, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$1.03
0.065[6.74%]
At close: Aug 12
$1.03
After Hours: 4:02PM EDT
Day High/Low0.91 - 1.06
52 Week High/Low0.75 - 2.51
Open / Close0.96 / 1.03
Float / Outstanding34.6M / 46.6M
Vol / Avg.561.3K / 293.9K
Mkt Cap48M
P/E-
50d Avg. Price1
Div / Yield-
Payout Ratio-
EPS-0.18
Total Float34.6M

Corvus Pharmaceuticals (NASDAQ:CRVS), Quotes and News Summary

Corvus Pharmaceuticals (NASDAQ: CRVS)

Day High/Low0.91 - 1.06
52 Week High/Low0.75 - 2.51
Open / Close0.96 / 1.03
Float / Outstanding34.6M / 46.6M
Vol / Avg.561.3K / 293.9K
Mkt Cap48M
P/E-
50d Avg. Price1
Div / Yield-
Payout Ratio-
EPS-0.18
Total Float34.6M
Sector: Health Care.Industry: Biotechnology
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the most critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers and autoimmune diseases. The company's lead product candidate is CPI-006 which is a potent humanized monoclonal antibody that is designed to react with a specific site on CD73. Its other product candidates are CPI-818, CPI-935, CPI-182 and Ciforadenant.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Corvus Pharmaceuticals Questions & Answers

Q
How do I buy Corvus Pharmaceuticals (CRVS) stock?
A

You can purchase shares of Corvus Pharmaceuticals (NASDAQ: CRVS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Corvus Pharmaceuticals's (CRVS) competitors?
Q
What is the target price for Corvus Pharmaceuticals (CRVS) stock?
A

The latest price target for Corvus Pharmaceuticals (NASDAQ: CRVS) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting CRVS to rise to within 12 months (a possible 288.35% upside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Corvus Pharmaceuticals (CRVS)?
A

The stock price for Corvus Pharmaceuticals (NASDAQ: CRVS) is $1.03 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Corvus Pharmaceuticals (CRVS) pay a dividend?
A

The next Corvus Pharmaceuticals (CRVS) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Corvus Pharmaceuticals (NASDAQ:CRVS) reporting earnings?
A

Corvus Pharmaceuticals’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Corvus Pharmaceuticals (CRVS) going to split?
A

There is no upcoming split for Corvus Pharmaceuticals.

Q
What sector and industry does Corvus Pharmaceuticals (CRVS) operate in?
A

Corvus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.